CNC Centene Corporation
Healthcare$57.72+0.00%OpenMarket Cap: $28.50B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.36
P/S
0.15
EV/EBITDA
-4.76
DCF Value
$127.46
FCF Yield
21.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
14.9%
Operating Margin
-3.7%
Net Margin
-3.3%
ROE
-28.7%
ROA
-7.9%
ROIC
-17.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $49.94B | 21.9% | $1.86B | $1.54B | $— | — |
| Q4 null | $49.73B | 15.2% | $-1.74B | $-1.10B | $— | — |
| FY null | $194.78B | 12.2% | $-7.62B | $-6.67B | $— | — |
| Q3 null | $49.69B | 16.4% | $-6.95B | $-6.63B | $— | — |
| Q2 null | $48.74B | 6.0% | $-458.0M | $-253.0M | $— | — |
| Q1 null | $46.62B | 11.2% | $1.53B | $1.31B | $— | — |
| Q4 null | $40.80B | 9.1% | $175.0M | $283.0M | $— | — |
| FY null | $163.07B | 10.3% | $3.17B | $3.31B | $— | — |
| Q3 null | $42.02B | 9.6% | $665.0M | $713.0M | $— | — |
| Q2 null | $39.84B | 11.1% | $1.23B | $1.15B | $— | — |
| Q1 null | $40.41B | 11.5% | $1.11B | $1.16B | $— | — |
| Q4 2023 | $39.46B | 9.3% | $-194.0M | $45.0M | $0.08 | — |